Schedule 13D ownership disclosure

PELTHOS THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 171126204

Event date: 2025-07-01

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Ezra FriedbergReported CIK 0001679440

    Shares: 250,121.00 · Class: 8.3%

  • Balmoral Financial Group LLCReported CIK 0001988769

    Shares: 92,072.00 · Class: 3.1%

  • Key Recovery Group LLC

    Shares: 40,000.00 · Class: 1.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-25-001081
Form type
SCHEDULE 13D/A
Filer
Friedberg Ezra M
CIK
CIK 1679440
Filed
Jul 03, 2025
Reporting period
Jul 01, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub